Home / Intelligence / Briefs / Making the Leap From Pharma to Pre-Commercial: A Field Guide for the New CCO
By Curt Staab, TGaS® Advisors, a division of Trinity
Executive Summary
TGaS® Advisors’ Emerging Life Sciences Network (elsN) has gathered advice and lessons learned from a broad-based CCO peer network to create this guide, the first in a series designed to help CCOs manage day-to-day and for the long-term. In this White Paper, we provide an overview of a CCO’s responsibilities, resources and expectations. Future issues will offer advice from peers and experts on launch planning and hiring.
To learn more, contact Curt Staab at cstaab@tgas.com.
Related Intelligence
White Papers
2023 Annual Digital Marketing Competency Report
Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates the brands across five categories and more than 100 characteristics to understand each one’s digital marketing presence and establish a […]
Read More
White Papers
The Globalization Marathon: Is Pharma Commercial Operations Moving to a Full Global Operating Model?
In the pharmaceutical industry, there has been ongoing discussion whether the Commercial Operations departments should become a globalized function. Over the past decade as companies have become more global in commercializing their products, organizations have been investigating the effectiveness of the Commercial Operations ecosystem. For 20 years, TGaS Advisors, a Division of Trinity Life Sciences, […]
Read More
White Papers
TGaS Annual MarTech and AdTech Landscape
Navigating the MarTech Jungle: An Analysis of The Technology Powering 160+ Pharma Brands. In today’s hyperconnected digital landscape, the marketing technology (MarTech) space has exploded into a complex ecosystem of over 10,000 potential vendors and services. The sheer volume of available options presents opportunities for pharmaceutical brands to optimize their performance and gain a competitive […]
Read More